Mechanism of Experimental Diabetic Cardiomyopathy Development
Journal Title: Міжнародний ендокринологічний журнал - Year 2012, Vol 42, Issue 2
Abstract
In experiment on 48 rats Na,K-ATPase and acetylcholinesterase activity was investigated in order to study the intensity and subsequence of cardiomyocyte membrane injuries induced by diabetic cardiomyopathy. The results and literature data allow conclude that diabetes-induced cardiomyopathy firstly affect transport processes in cardiomyocyte membrane. Long-term diabetes mellitus is associated with impaired cholinergic regulation.
Authors and Affiliations
D. A. Yefimov
Keywords
Related Articles
- EP ID EP623575
- DOI -
- Views 34
- Downloads 0
Photoperiodism and Function of the Reproductive System in Mammals and Human
It is found that the change of day length affects the timing of puberty, depending on the action of light status in the prenatal or postnatal ontogenesis.
Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy
Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy
Peculiarities of Styfimol impact on carbohydrate, lipid metabolism and blood adipokine levels in patients with type 2 diabetes with obesity and arterial hypertension
Background. The purpose of the study was to evaluate the impact of treatment with a fixed combination of the extract of garcinia cambogia 0.1 g (equivalent to hydroxycitric acid 0.05 g), chromium picolinate 0.0001 g, L-...
Analysis of Medical Status of Patients with Type 2 Diabetes Mellitus and Its Impact on the Development of Complications
The assessment of quality of diabetes care in the implementation of new clinical protocol is an urgent problem. The objective of the study — to assess the medical status of patients with type 2 diabetes mellitus accordin...
Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)
The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogeni...